Skip to main content

Table 3 Interval follow-up variables: For all cases (n = 304), for cases in which an attempt to completely excise the breast lesion was made (n = 235), and for cases in which only diagnostic tissue sampling of the breast lesion was undertaken (n = 69)

From: A comprehensive evaluation of the 8-gauge vacuum-assisted Mammotome® system for ultrasound-guided diagnostic biopsy and selective excision of breast lesions

 

All cases

(n = 304)

Attempted lesion excision

(n = 235)

Only diagnostic lesion sampling

(n = 69)

P-value

Was any IFU done by patient?

   

0.678

   Yes

256

(84%)

199

(85%)

57

(83%)

 

   No

48

(16%)

36

(15%)

12

(17%)

 

Was IFU imaging performed?

   

<0.001

   Yes

189

(62%)

170

(72%)

19

(28%)

 

   No

51

(17%)

38

(16%)

13

(19%)

 

   Instead had subsequent excisional breast procedure performed

64

(21%)

27

(12%)

37

(54%)

 

Median time to IFU imaging (months) for those (n = 189) undergoing IFU imaging

6

(3–16)

6

(3–16)

6

(3–8)

0.110

Was IFU ultrasound performed?

   

<0.001

   Yes

188

(62%)

170

(72%)

18

(26%)

 

   No

52

(17%)

38

(16%)

14

(20%)

 

   Instead had subsequent excisional breast procedure performed

64

(21%)

27

(12%)

37

(54%)

 

Was a residual ultrasound lesion visible for those undergoing IFU ultrasound (n = 188)?

   

<0.001

   Yes

34

(18%)

19

(11%)

15

(83%)

 

   No

154

(82%)

151

(89%)

3

(17%)

 

Was IFU mammogram performed?

   

<0.001

   Yes

179

(59%)

162

(69%)

17

(25%)

 

   No

61

(20%)

46

(20%)

15

(22%)

 

   Instead had subsequent excisional breast procedure done

64

(21%)

27

(12%)

37

(54%)

 

Was a residual mammographic lesion visible for those undergoing IFU mammogram (n = 179)?

   

0.001

   Yes

11

(6%)

6

(4%)

5

(29%)

 

   No

168

(94%)

156

(96%)

12

(71%)

 

For those undergoing a pre-procedural mammogram (which demonstrated a mammographic lesion) and who had both an IFU ultrasound and an IFU mammogram, was a residual ultrasound lesion visible on IFU ultrasound (n = 110)?

   

<0.001

   Yes

21

(19%)

14

(14%)

7

(88%)

 

   No

89

(81%)

88

(86%)

1

(12%)

 

For those undergoing a pre-procedural mammogram (which demonstrated a mammographic lesion) and who had both an IFU ultrasound and an IFU mammogram, was a residual mammographic lesion visible on IFU mammogram (n = 110)?

   

0.001

   Yes

9

(8%)

5

(5%)

4

(50%)

 

   No

101

(92%)

97

(95%)

4

(50%)

 

Median duration of IFU (months) for those (n = 256) undergoing IFU

11

(1–37)

9

(2–37)

13

(1–30)

0.146

  1. IFU, Interval follow-up